Terms: = Prostate cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Diagnosis
478 results:
1. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
Hemminki K; Zitricky F; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki O
Cancer Med; 2024 Apr; 13(7):e7126. PubMed ID: 38545829
[TBL] [Abstract] [Full Text] [Related]
2. Decline in cancer Diagnoses during the 'Zero COVID' Policy in Hong Kong: Indirect Spillover Impact of the COVID-19 Pandemic.
Youn HM; Zhang Y; Liu A; Ng CS; Liang J; Lau GKK; Lee SF; Lok J; Lam CLK; Wan EYF; Quan J
Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):157-164. PubMed ID: 38262779
[TBL] [Abstract] [Full Text] [Related]
3. Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy.
Ozawa Y; Nohara S; Nakamura K; Hattori S; Yagi Y; Nishiyama T; Yorozu A; Monma T; Saito S
Prostate; 2024 Apr; 84(5):502-510. PubMed ID: 38173289
[TBL] [Abstract] [Full Text] [Related]
4. Mapping the contributions of dyadic approaches to couples' psychosocial adaptation to prostate cancer: a scoping review.
Castro RF; Araújo S; Marques A; Ferreira D; Rocha H; Aguiar S; Pieramico S; Quinta-Gomes A; Tavares IM; Nobre PJ; Carvalho J
Sex Med Rev; 2023 Dec; 12(1):35-47. PubMed ID: 37930753
[TBL] [Abstract] [Full Text] [Related]
5. Orthopaedic surgeons' ability to detect pathologic hip fractures: review of 1484 fractures reported to the Norwegian Hip Fracture Register.
Sund A; Dybvik E; Gjertsen JE
J Orthop Surg Res; 2023 Nov; 18(1):832. PubMed ID: 37925444
[TBL] [Abstract] [Full Text] [Related]
6. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract] [Full Text] [Related]
7. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
[TBL] [Abstract] [Full Text] [Related]
8. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system.
Herr DJ; Elliott DA; Duchesne G; Stensland KD; Caram MEV; Chapman C; Burns JA; Hollenbeck BK; Sparks JB; Shin C; Zaslavsky A; Tsodikov A; Skolarus TA
Cancer; 2023 Oct; 129(20):3326-3333. PubMed ID: 37389814
[TBL] [Abstract] [Full Text] [Related]
10. Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study.
Crump C; Stattin P; Brooks JD; Sundquist J; Edwards AC; Sieh W; Sundquist K
JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37389442
[TBL] [Abstract] [Full Text] [Related]
11.
Alzoubi A; Al Bashir S; Smairat A; Alrawashdeh A; Haddad H; Kheirallah K
J Med Life; 2023 Apr; 16(4):593-598. PubMed ID: 37305830
[TBL] [Abstract] [Full Text] [Related]
12. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
13. Testosterone Treatment of Men with Unequivocal Hypogonadism Following Treatment of Organ-Confined prostate cancer.
Jones RB; Snyder PJ
Endocr Pract; 2023 Sep; 29(9):723-726. PubMed ID: 37236354
[TBL] [Abstract] [Full Text] [Related]
14. Increased Burden of Second Bladder cancer and Rectal cancer in prostate cancer Treated With Radiotherapy: Results From Surveillance, Epidemiology, and End Results.
Lin J; Zhan X; Chen R; Chen T; Jiang M; Li Y; Liu X; Chen G; Fu B
Cancer Control; 2023; 30():10732748231177544. PubMed ID: 37196346
[TBL] [Abstract] [Full Text] [Related]
15. Neighbourhood social deprivation and risk of prostate cancer.
Salmon C; Quesnel-Vallée A; Barnett TA; Benedetti A; Cloutier MS; Datta GD; Kestens Y; Nicolau B; Parent MÉ
Br J Cancer; 2023 Aug; 129(2):335-345. PubMed ID: 37188877
[TBL] [Abstract] [Full Text] [Related]
16. Family structure and living arrangements as indicators of social isolation, and prostate cancer risk.
Salmon C; Quesnel-Vallée A; Parent MÉ
Prev Med; 2023 Jul; 172():107544. PubMed ID: 37178831
[TBL] [Abstract] [Full Text] [Related]
17. Long-term Risks of Depression and Suicide Among Men with prostate cancer: A National Cohort Study.
Crump C; Stattin P; Brooks JD; Sundquist J; Bill-Axelson A; Edwards AC; Sundquist K; Sieh W
Eur Urol; 2023 Sep; 84(3):263-272. PubMed ID: 37169640
[TBL] [Abstract] [Full Text] [Related]
18. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract] [Full Text] [Related]
19. Trends in the age of hospitalized patients with urological cancers: A 17-year experience.
Ishii N; Hatakeyama S; Miura H; Tanaka R; Oishi T; Horiguchi H; Hosogoe S; Fujita N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
Int J Urol; 2023 Jul; 30(7):572-578. PubMed ID: 36941076
[TBL] [Abstract] [Full Text] [Related]
20. cancer survival in the northwestern of São Paulo State, Brazil: A population-based study.
Mafra A; Bardot A; Charvat H; Weiderpass E; Soerjomataram I; Fregnani JHTG
Cancer Epidemiol; 2023 Apr; 83():102339. PubMed ID: 36863216
[TBL] [Abstract] [Full Text] [Related]
[Next]
